¿­·¢K8Æì½¢Ìü

À´Ô´£ºÊÓ¾õϵ²å»­ £¬×÷Õߣº  £¬£º

°¥ £¬Äã¶®¸öƨ£¡ÏÐÓãÉÏÄÇЩºÚ»° £¬ÕæÊǰÑÈËÈÆÔÎÁË

ÕÕÎÒ˵Âï £¬Ò»ÌáÕâ¡°ÏÐÓãÕÐæÎÇпڴóÈ«¡± £¬ÌýמÍаºõ £¬É¶¡°Æ·Üø¡±¡¢¡°ÑøÓ㡱¡¢¡°Ð޽š± £¬ÄãËÃ÷ÈÕâ´Ê¶ùÊǸÉɶÓÃÁ¨ £¿Ç°¼¸Ìì°³½ÖÉÏÅö¼û¸öÄêÇáÈË £¬ËµËûÔÚÏÐÓãÉÏ¿´µ½ÕâЩÇпÚ £¬»¹ÒÔΪÊÇÂô²èÒ¶¡¢ÂôÓãµÄ¡£ÎÒÌýמͻðÁË £¬ÕæÊǰ׳¶µ­£¡Äã˵ £¬Ë­»áÌ©×ÓÒ¹ÏÐ×ÅûÊÂÂò²èÒ¶ £¿¹í²ÅÐÅߣ¡

ÄÇÄêÇáÈË»¹¸úÎÒ̧¸Ü £¬ËÃ÷ÈÕâʶù¿ÉÄܸúºÓÄÏÔÛÀϱ²×ÓÑøÓãµÄϰË×ÓÐµã¹ØÏµ¡£ÎÒÅÞ£¡ÎÒÄêÇáÄÇʱºò £¬°³µùÔÚ´åÀïÑøÓã £¬Ë­¼û¹ýÓãÌÁÀïÁíÓÐɶ¡°Æ·Üø¡±µÄµÀµÀ £¿ÕâÏÐÓãÉϵÄÄÇЩºÚ»° £¬»ù´¡²»ÊÇÔÛºÓÄÏÈ˵ĹŰåɶʶù £¬´¿´âÊǺöÓÆÈ˵ÄÍæÒâ¶ù¡£

ÕÕÎÒ¸øÄãêþ³¶Çå³þ £¬Õâ±³ºóèÄå±ÈÖ£Öݺúͬ»¹ÈÆ£¡

ÏÐÓãÉϵġ°Çпڡ±¾¿¾¹ÊÇÕ¦»ØÊ £¿ÄãÌýºÃà¶£¡

ÏÐÓãÉÏÄÇЩËùνµÄ¡°ÕÐæÎÇпڡ± £¬Æäʵ¾ÍÊÇÍæÎÄ×ÖÓÎÏ·ß¡£É¶¡°Æ·Üø¡± £¬Æäʵ²»ÊÇÆ·Üø£»É¶¡°Ð޽š± £¬¸ü²»ÊÇÐ޽š£È˼ҾÍÊÇ´ò²Á±ßÇò £¬ÅªÄÇЩÈÃÈË¿´²»Ã÷°×µÄ´Ê¶ùÀ´ÑÚ¸ÇÕæÕýµÄÒâ˼¡£Ò»°ãÇé¿öÂï £¬ÕâЩÇпڶ¼ÊÇΪÁ˹æ±ÜÏÐÓãÆ½Ì¨µÄÉóºË¹æÔò £¬ÈÃÆ½Ì¨¿´²»³öÀ´ÕâÊÇÎ¥·¨µÄ½»Òס£

°¥ £¬ÄãÌý×Å£¡ÕâЩºÚ»°ÀïÍ· £¬×î³£¼ûµÄÌ×·¾ÍÊÇÓÃÈÕ³£´Ê»ã×°ÎÞ¹¼ £¬ºÃ±È¡°²è¡±´ú±íЧÀÍ £¬¡°Ó㡱´ú±í¿Í»§¡£ÔÙ¼ÓÉϼ۸ñ±ê×¢µÃģģºýºý £¬ºÃ±È¡°88ﻮᆿ¡± £¬ÄãÒªÊÇÕæ²»¶® £¬±£×¼±»ÈÆÔΡ£±ðϹÐÅ £¬ÕæÓÐɶʶù £¬¿Ï¶¨²»ÊÇÃ÷ÃæÉÏ˵µÄÕâô¼òµ¥¡£

ΪɶƫƫÏÐÓã £¿Æ½Ì¨¹æÔòºÍÔÛºÓÄϵġ°ÈËÇéÉç»á¡±ÓеãÏàËÆ

Äã˵ΪɶÕâЩÈËÆ«°®ÏÐÓã×öÕâʶù £¿ÕÕÎÒ×ÁÄ¥Âï £¬ÏÐÓã¸úÔÛºÓÄÏÈ˵ġ°ÈËÇéÉç»á¡±ÓеãÏñ¡£ÔÛºÓÄÏÈ˽²¾¿É¶ £¿½²¾¿¹ÕÍäĨ½Ç¡¢Áô¸öÃæ×Ó £¬ÈËÇéÊÀ¹ÊÈÆµÃ¸úÖ£ÖÝÀϳÇÇøµÄºúͬһÑù¡£ÏÐÓãÒ²ÊÇÕâ·×Ó £¬½»Ò×¶¼Êǰ뿪·ÅµÄ £¬ÓÖÓеã˽ÃÜ £¬ÕýºÃÈÃÕâЩÈË×êÁË¿Õ×Ó¡£

²»¹ýÄãÌýºÃÁË £¬ÔÛºÓÄÏÈ˹ÕÍäĨ½ÇÊÇΪÁ˽²ÇéÃæ £¬ÏÐÓãÕâʶùÈ´ÊÇΪÁ˶ã¼à¹Ü £¬ÐÔÖÊÍêÈ«·×ÆçÑù£¡±ðÄÃÔÛºÓÄÏÈ˵ĺÃϰ¹ß¸úÕâЩºÚ»°»ìΪһ̸ £¬ÎÒÌýÁ˾ÍÀ´Æø£¡

×ܽ᣺±ð±»ÕâЩºÚ»°ºöÓÆ £¬¸ô×ÅÆÁĻ˭֪µÀ¶Ô·½ÊÇɶÈË

ÕÕÎÒ˵Âï £¬ÏÐÓãÉϵÄÕâЩÕÐæÎÇпÚ £¬¾Í¸ú·±ß̯ÉϵļٻâÃæÒ»Ñù £¬¿´×ÅÓеãÏñ £¬³ÔÆðÀ´È´Ò»µã×Ìζ¶¼ƒÓ¡£ÄãÒªÕæÏë¸ãÃ÷°× £¬ÕվɵòÁÁÁÑÛ¾¦ £¬¶à³¤µãÐÄ¡£±ðÒÔΪÈ˼Ò˵ɶ¾ÍÐÅɶ £¬¸ô×ÅÆÁÄ» £¬Ë­ÖªµÀ¶Ô·½ÊÇÈËÊǹí £¿


Äã¿ÉÄÜÎÊ£ºÄÇÈç¹ûÕæÓöÉÏÕâЩºÚ»° £¬¸ÃÕ¦°ì £¿

Ïà¹ØÍ¼Æ¬

ÎÒ¸æËßÄã £¬¿´µ½ÕâЩÇпÚ £¬Ö±½Ó¾Ù±¨ß£¡±ð°×ϹÁËÆ½Ì¨µÄ¾Ù±¨¹¦Ð§¡£ÁíÓÐ £¬Æ½Ê±¶àѧµãÌ×· £¬ÃâµÃÈÃÈËÈÆµÃÍ·ÔΡ£ÄãÌý°³µÄ £¬×¼ÖУ¡

±êÇ©£º

  • ÏÐÓãÕÐæÎÇпڴóÈ«
  • ºÓÄÏÈËÇéÉç»á
  • Æ·ÜøºÚ»°
  • ƽ̨¼à¹Ü©¶´
  • ¹ÕÍäĨ½Ç
Ïà¹ØÍ¼Æ¬

¡¶ÓÐÇ®ÈËȥİİÕÒÅ®ÈËÂð¡·

ÔÚ´ËÅä¾°Ï £¬4ÔÂ9ÈÕ19:30 £¬¡¶ÕÅÈï»á¿ÍÌü¡·½«ÍƳöרÌâÖ±²¥¡ª¡ª¡°100%¹ØË°2.0£ºÃÀ¹ú½ø¿ÚרÀûÒ©ÐÂÕþÂ䵨 £¬ÖйúÒ©ÆóµÄ³öº£Âß¼­ÈçºÎÖØ¹À £¿¡±¡£ÌØÑû±ÏÂíÍþÃÀ¹ú¸ß¼¶Ë°Îñ×ܼ೵Èð¡¢Latitude Health£¨ÏçÈËÈռǣ©Ê×´´ÈËÕԺ⠣¬ÓëÕÅÈïÀÏʦ£¨Ö÷ÀíÈË£©ÅäºÏ²ð½âÐÐÕþÁî½¹µãÌõ¿î £¬±ÈÕÕÈ¥Äê9Ô¡°º°»°¡±Óë´Ë´ÎÕýʽǩÁîµÄÒªº¦²î±ð £¬ÆÊÎöBig Pharma¡¢Biotech¼°API/CDMOÆóÒµ¸÷×ÔÃæÁÙµÄΣº¦ÓëÓ¦¶ÔÕ½ÂÔ £¬²¢Ì½Ìָ߹ØË°ÏÂÖйúÁ¢ÒìÒ©ÈçºÎ´ÓÒÀÀµÃÀ¹úתÏòÈ«Çò¶à¼«»¯½á¹¹¡£½Ó´ýԤԼԢĿ £¬¹²Òé³öº£ÐÂÆå¾Ö£¡

¡¶¸ß¶ËÄ£ÌØÔ¤Ô¼ÉÏÃÅ¡·

ÈÕÍâµØ´¦È«Çò×î»îÔ¾µÄµØ¶¯´ø¡ª¡ª»·Ì«Æ½Ñ󵨶¯´øÉÏ £¬ÕâÒ²ÊÇÈ«ÇòµØ¶¯×î¶àµÄµØ¶¯´ø¡£(Íê)

¡¶699Ìײ͵ÄÃÃ×ÓÒ»°ã¸ÉÂï¡·

ÒÔÌõ¼Ç±¾ÎªÀý £¬¾ÝCounterpoint ResearchÊý¾Ý £¬2025ÄêÈ«ÇòÌõ¼Ç±¾µçÄÔÃæ°åÊг¡Í¬±ÈÔö³¤7% £¬ÆäÖи߶ËÃæ°å£¨MiniLEDÓëOLED£©Ôö·ù´ï19%¡£Õ¹Íû2026Äê £¬´æ´¢±¾Ç®ÉÏÕÇѹÁ¦Á¬Ðø £¬ÕûÌåÊг¡Ô¤¼ÆÏ»¬5% £¬µ«OLEDÃæ°åÈÔ½«Ôö³¤33%¡£

ÍøÕ¾µØÍ¼